Remus Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 13, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	7,898	13,192	10,163	-	-	-
Market Cap Growth	-36.72%	29.81%	-	-	-	-
Enterprise Value	8,159	13,164	10,212	-	-	-
Last Close Price	677.50	1118.05	860.48	-	-	-
PE Ratio	24.76	45.38	49.53	-	-	-
PS Ratio	1.06	2.13	4.77	-	-	-
PB Ratio	2.34	4.67	5.80	-	-	-
P/TBV Ratio	2.65	5.34	6.83	-	-	-
P/FCF Ratio	352.60	439.73	-	-	-	-
P/OCF Ratio	116.49	189.00	752.80	-	-	-
EV/Sales Ratio	1.09	2.12	4.80	-	-	-
EV/EBITDA Ratio	15.87	29.25	35.56	-	-	-
EV/EBIT Ratio	16.66	30.04	36.68	-	-	-
EV/FCF Ratio	364.24	438.80	-	-	-	-
Debt / Equity Ratio	0.05	0.08	0.08	0.42	0.03	0.09
Debt / EBITDA Ratio	0.31	0.50	0.49	0.71	0.04	0.21
Debt / FCF Ratio	7.15	7.66	-	3.08	0.04	0.10
Net Debt / Equity Ratio	-0.01	-0.01	-0.06	0.26	-0.14	-0.18
Net Debt / EBITDA Ratio	-0.10	-0.09	-0.37	0.44	-0.22	-0.41
Net Debt / FCF Ratio	-2.20	-1.43	5.53	1.90	-0.19	-0.20
Asset Turnover	1.90	1.62	1.16	1.79	1.84	2.30
Inventory Turnover	9.08	11.26	7.53	22.88	8.96	14.50
Quick Ratio	0.87	1.11	0.99	0.97	0.44	0.58
Current Ratio	1.61	1.82	1.51	1.39	0.84	0.98
Return on Equity (ROE)	18.30%	16.79%	24.98%	66.14%	71.37%	40.49%
Return on Assets (ROA)	7.75%	7.15%	9.46%	26.40%	19.63%	8.89%
Return on Invested Capital (ROIC)	11.64%	16.06%	23.77%	53.60%	77.53%	47.79%
Return on Capital Employed (ROCE)	13.10%	14.10%	14.50%	40.30%	63.30%	34.60%
Earnings Yield	4.24%	2.20%	2.02%	-	-	-
FCF Yield	0.28%	0.23%	-0.19%	-	-	-
Dividend Yield	0.15%	0.07%	0.09%	-	-	-
Payout Ratio	1.76%	4.06%	2.88%	-	-	-
Buyback Yield / Dilution	-3.88%	-4.28%	-38.35%	-2.10%	-	-
Total Shareholder Return	-3.74%	-4.21%	-38.27%	-2.10%	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.